简体中文 | 繁體中文 | English

Products & Services News

2022-03-16 14:21 Quanergy Participates at ISC West to Showcase 3D LiDAR Solutions for Advanced Security and Business Intelligence
2022-03-16 14:16 Skyline Development: Developer of The One Bel-Air Mega Mansion Seeks New Investors Before March 18 Deadline
2022-03-16 11:33 Zayed Sustainability Prize Opens Submissions for 2023 Cycle
2022-03-16 10:29 Andersen Global Inaugurates Member Firm in the United Arab Emirates
2022-03-16 10:25 Napier Continues EMEA Expansion to Meet Demand for Advanced AI-Enhanced AML Solutions
2022-03-16 09:35 ReadSpeaker Unveils First-Ever Text-to-Speech Multi-Platform Plugin for Unreal and Unity Game Engines
2022-03-15 19:14 Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management
2022-03-15 19:12 Vbrick Continues to Show Strong Revenue Growth in 2021
2022-03-15 19:10 Encina Announces $55 Million of Committed Financing Supported by IMM Investment Global Limited
2022-03-15 15:37 TDCX Announces US$30 Million Share Repurchase Program Highlighting Confidence in Growth
2022-03-15 15:14 Nichi GLOW: Japanese Beta-Glucan, in Children With Autism Spectrum Disorder, Improves Behavior, Sleep, and Gut Microbiome in a Clinical Study
2022-03-15 13:32 Bluehole Publishes an Industry Comment on China's First Corporate Risk Assessment Laboratory for the EUTPD Compliance
2022-03-15 09:32 PROMPERÚ: Peruvian Trade Mission in Dubai Will Reach Deals for US$30 Million
2022-03-14 13:36 Wayback Burgers Opens in Japan
2022-03-14 13:26 O2 Telefónica and Mavenir Demonstrate Zero Touch CI/CD Based Operations of IMS Core on Cloud Infrastructure
2022-03-14 10:52 Alvotech Resolves U.S. Patent and Trade Secret Disputes with AbbVie, Securing U.S. Rights for Alvotech’s Proposed High-Concentration Biosimilar (AVT02) for Humira®
2022-03-14 10:17 Makers Fund Raises $500 Million Fund III to Power Growth and Innovation in Interactive Entertainment
2022-03-14 10:10 Western Union Suspends Operations in Russia and Belarus
2022-03-14 10:08 The Result of the Phase 3 Study for Prestige BioPharma’s Herceptin Biosimilar, HD201(Tuznue®), Published in JAMA Oncology
2022-03-14 10:05 EKF Life Sciences and ABEC Partner for US Biomanufacturing Expansion

Business Wire Weibo

Press Releases

Latest Releases